Form 8-K - Current report:
SEC Accession No. 0001564590-20-052731
Filing Date
2020-11-10
Accepted
2020-11-10 07:10:55
Documents
2
Period of Report
2020-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arav-8k_20201106.htm 8-K 34971
2 EX-10.1 arav-ex101_6.htm EX-10.1 574993
  Complete submission text file 0001564590-20-052731.txt   611177
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 201299605
SIC: 2834 Pharmaceutical Preparations